Pacira BioSciences, Inc.

SEC 4 · Filed

0001628280-26-043003Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jun 10, 2026

Grant, award or other acquisition by Froimson Mark

Security
Stock Option (Right to Buy)
Code
A
Shares
10,891
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-06-10",
  "direction": "A",
  "exercise_price": "23.42",
  "expiration": "2036-06-10",
  "footnotes": {
    "F2": "The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date."
  },
  "owners": [
    {
      "cik": "0001709050",
      "name": "Froimson Mark",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "10891",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock Option (Right to Buy)",
  "shares": "10891",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "10891"
}
Insider transactionsEvent date Jun 10, 2026

Grant, award or other acquisition by Froimson Mark

Security
Common Stock
Code
A
Shares
6,405
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-06-10",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer\u0027s common stock."
  },
  "owners": [
    {
      "cik": "0001709050",
      "name": "Froimson Mark",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "26541",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "6405",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}